{"id":17336,"date":"2025-06-09T15:16:31","date_gmt":"2025-06-09T13:16:31","guid":{"rendered":"https:\/\/www.pharmanutra.it\/?p=17336"},"modified":"2025-06-27T09:02:15","modified_gmt":"2025-06-27T07:02:15","slug":"iron-deficiency-oncology-interview-sandro-barni-imcid-2025","status":"publish","type":"post","link":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/","title":{"rendered":"Iron Deficiency in Oncology: A Still Overlooked Clinical Challenge"},"content":{"rendered":"\n

At IMCID 2025, Dr. Sandro Barni highlights the importance of iron supplementation in oncology and the emerging role of iron metabolism in therapeutic pathways.<\/h2>\n\n\n\n

The ninth edition of the International Multidisciplinary Course on Iron Deficiency (IMCID)<\/a><\/strong>, held in Palermo, gathered specialists and researchers from around the world to review the most recent scientific evidence on iron deficiency\u2014a condition that affects numerous clinical areas. Among the key contributors to the 2025 scientific program was Dr. Sandro Barni<\/strong>, Director Emeritus of Oncology at ASST BG Ovest \u2013 Treviglio Hospital<\/strong>, who participated as a member of the Scientific Committee and chair of the session dedicated to oncology. In this interview, he discusses the increasingly strategic role of iron in oncology practice.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
\n\n\n\n

Doctor, what makes this edition of IMCID particularly significant compared to previous ones?<\/strong><\/strong><\/p>\n\n\n\n

\n

I believe this congress is truly unique and has become a reference point for the scientific community. Iron deficiency is a topic that rarely gets space in major medical conferences, whereas here it is addressed in depth and from a multidisciplinary perspective. Today, we finally have a growing body of scientific publications demonstrating the concrete clinical impact of iron deficiency. For too long, this issue has been underestimated. Now, it is at the center of renewed attention, and IMCID is playing a crucial role in highlighting its importance.<\/em><\/p>\n<\/blockquote>\n\n\n\n

Anaemia is a frequent and complex issue in oncology. What are the latest recommendations for managing iron deficiency in this setting?<\/strong><\/strong><\/p>\n\n\n\n

\n

Anaemia, especially when severe, can prevent the continuation of oncological treatments\u2014particularly systemic therapies, but also radiotherapy, which is highly sensitive to the hypoxia caused by reduced haemoglobin levels. It is therefore essential to prevent and manage this condition promptly.
We know that between 50% and 60% of oncology patients already present with iron deficiency or even overt anaemia at their first visit<\/strong>. This tendency worsens over time due to the toxic effects of chemotherapy, hormone therapy, targeted therapies, immunotherapy, and more recently, ADCs. If iron deficiency and\/or anaemia are not corrected, we often have to reduce doses or discontinue treatments, with a negative impact on clinical outcomes.<\/em><\/p>\n<\/blockquote>\n\n\n\n

Can iron metabolism directly influence tumour progression?<\/strong><\/strong><\/p>\n\n\n\n

\n

That\u2019s a complex question. At the moment, we do not yet have conclusive data to establish a direct causal link. However, it is clear that failing to correct iron deficiency leads to interruptions and dose reductions in treatment, which can in turn worsen disease progression. So, even indirectly, iron metabolism certainly has a significant impact on prognosis.<\/em><\/p>\n<\/blockquote>\n\n\n\n

Are there clinical scenarios in which iron supplementation proves especially decisive?<\/strong><\/strong><\/p>\n\n\n\n

\n

Yes, and today we have increasingly solid evidence. At this edition of IMCID, for instance, two studies were presented on the use of Sucrosomial\u00ae Iron in combination with chemotherapy and chemoradiotherapy<\/strong>. In both cases, supplementation made it possible to maintain stable haemoglobin levels, avoiding treatment interruptions.
This is a clear benefit both for patients and the healthcare system: we reduce the need for transfusions or erythropoiesis-stimulating agents, leading to improved quality of care and better resource optimization.<\/em><\/p>\n<\/blockquote>\n\n\n\n

\n\n\n\n

In today\u2019s oncology landscape, iron is no longer just a laboratory parameter to monitor, but a true therapeutic tool. Dr. Barni\u2019s contribution at IMCID 2025<\/strong> reaffirmed that managing iron deficiency\u2014and the resulting iron-deficiency anaemia\u2014is a crucial component for ensuring continuity and effectiveness in cancer treatments. A clear message, supported by new evidence, that confirms the value of a multidisciplinary, evidence-based approach in modern medicine.<\/p>\n\n\n\n

\n\n\n\n

The\u00a0Abstract Book of the 9th<\/sup>\u00a0IMCID\u00a0<\/strong>\u2013 International Multidisciplinary Course on Iron Deficiency, held in Palermo (Sicily, Italy) from 3 to 4 April 2025, has been published as Supplement n\u00b03 of the last issue of May 2025 of the international journal\u00a0Blood Transfusion (IF=2.4)<\/em><\/strong>.
Download the abstract book here!<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

At IMCID 2025, Dr. Sandro Barni highlights the importance of iron supplementation in oncology and the emerging role of iron metabolism in therapeutic pathways. The ninth edition of the International Multidisciplinary Course on Iron Deficiency (IMCID), held in Palermo, gathered specialists and researchers from around the world to review the most recent scientific evidence on […]<\/p>\n","protected":false},"author":3,"featured_media":17329,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[96,1],"tags":[143,139,130],"anno_documento":[80],"class_list":["post-17336","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-iron-deficiency","category-senza-categoria","tag-congress","tag-eventi-en","tag-oncology","anno_documento-80"],"yoast_head":"\nIron Deficiency in Oncology: Evidence from IMCID 2025<\/title>\n<meta name=\"description\" content=\"At IMCID 2025, Dr. Sandro Barni highlights the relevance of addressing iron deficiency in oncology to optimize treatment continuity.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Iron Deficiency in Oncology: Evidence from IMCID 2025\" \/>\n<meta property=\"og:description\" content=\"At IMCID 2025, Dr. Sandro Barni highlights the relevance of addressing iron deficiency in oncology to optimize treatment continuity.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"pharmanutra.it\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-09T13:16:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T07:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Silvia Rigotto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silvia Rigotto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/\"},\"author\":{\"name\":\"Silvia Rigotto\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/e167594e059fd908b48f144590a46ccd\"},\"headline\":\"Iron Deficiency in Oncology: A Still Overlooked Clinical Challenge\",\"datePublished\":\"2025-06-09T13:16:31+00:00\",\"dateModified\":\"2025-06-27T07:02:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/\"},\"wordCount\":619,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg\",\"keywords\":[\"Congress\",\"Eventi\",\"Oncology\"],\"articleSection\":[\"Iron deficiency\",\"Senza categoria\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/\",\"url\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/\",\"name\":\"Iron Deficiency in Oncology: Evidence from IMCID 2025\",\"isPartOf\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg\",\"datePublished\":\"2025-06-09T13:16:31+00:00\",\"dateModified\":\"2025-06-27T07:02:15+00:00\",\"description\":\"At IMCID 2025, Dr. Sandro Barni highlights the relevance of addressing iron deficiency in oncology to optimize treatment continuity.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#primaryimage\",\"url\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg\",\"contentUrl\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"IMCID 2025 - Sandro Barni parla alla platea durante la sessione dedicata all'oncologia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.pharmanutra.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Iron Deficiency in Oncology: A Still Overlooked Clinical Challenge\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#website\",\"url\":\"https:\/\/www.pharmanutra.it\/en\/\",\"name\":\"pharmanutra.it\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.pharmanutra.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#organization\",\"name\":\"pharmanutra.it\",\"url\":\"https:\/\/www.pharmanutra.it\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/09\/PHN_LOGO2020color.png\",\"contentUrl\":\"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/09\/PHN_LOGO2020color.png\",\"width\":1856,\"height\":210,\"caption\":\"pharmanutra.it\"},\"image\":{\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/e167594e059fd908b48f144590a46ccd\",\"name\":\"Silvia Rigotto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/74de320c47466acb3ce41afd90e724ba09607692eb64df19e5d1a3518ea9984c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/74de320c47466acb3ce41afd90e724ba09607692eb64df19e5d1a3518ea9984c?s=96&d=mm&r=g\",\"caption\":\"Silvia Rigotto\"},\"url\":\"https:\/\/www.pharmanutra.it\/en\/author\/s-rigotto\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Iron Deficiency in Oncology: Evidence from IMCID 2025","description":"At IMCID 2025, Dr. Sandro Barni highlights the relevance of addressing iron deficiency in oncology to optimize treatment continuity.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/","og_locale":"en_US","og_type":"article","og_title":"Iron Deficiency in Oncology: Evidence from IMCID 2025","og_description":"At IMCID 2025, Dr. Sandro Barni highlights the relevance of addressing iron deficiency in oncology to optimize treatment continuity.","og_url":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/","og_site_name":"pharmanutra.it","article_published_time":"2025-06-09T13:16:31+00:00","article_modified_time":"2025-06-27T07:02:15+00:00","og_image":[{"width":1500,"height":1000,"url":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg","type":"image\/jpeg"}],"author":"Silvia Rigotto","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Silvia Rigotto","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#article","isPartOf":{"@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/"},"author":{"name":"Silvia Rigotto","@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/e167594e059fd908b48f144590a46ccd"},"headline":"Iron Deficiency in Oncology: A Still Overlooked Clinical Challenge","datePublished":"2025-06-09T13:16:31+00:00","dateModified":"2025-06-27T07:02:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/"},"wordCount":619,"commentCount":0,"publisher":{"@id":"https:\/\/www.pharmanutra.it\/en\/#organization"},"image":{"@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg","keywords":["Congress","Eventi","Oncology"],"articleSection":["Iron deficiency","Senza categoria"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/","url":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/","name":"Iron Deficiency in Oncology: Evidence from IMCID 2025","isPartOf":{"@id":"https:\/\/www.pharmanutra.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg","datePublished":"2025-06-09T13:16:31+00:00","dateModified":"2025-06-27T07:02:15+00:00","description":"At IMCID 2025, Dr. Sandro Barni highlights the relevance of addressing iron deficiency in oncology to optimize treatment continuity.","breadcrumb":{"@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#primaryimage","url":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg","contentUrl":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/06\/Barni_sessione-oncologia_imcid-2025.jpg","width":1500,"height":1000,"caption":"IMCID 2025 - Sandro Barni parla alla platea durante la sessione dedicata all'oncologia"},{"@type":"BreadcrumbList","@id":"https:\/\/www.pharmanutra.it\/en\/iron-deficiency-oncology-interview-sandro-barni-imcid-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pharmanutra.it\/en\/"},{"@type":"ListItem","position":2,"name":"Iron Deficiency in Oncology: A Still Overlooked Clinical Challenge"}]},{"@type":"WebSite","@id":"https:\/\/www.pharmanutra.it\/en\/#website","url":"https:\/\/www.pharmanutra.it\/en\/","name":"pharmanutra.it","description":"","publisher":{"@id":"https:\/\/www.pharmanutra.it\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pharmanutra.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.pharmanutra.it\/en\/#organization","name":"pharmanutra.it","url":"https:\/\/www.pharmanutra.it\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/09\/PHN_LOGO2020color.png","contentUrl":"https:\/\/www.pharmanutra.it\/wp-content\/uploads\/2025\/09\/PHN_LOGO2020color.png","width":1856,"height":210,"caption":"pharmanutra.it"},"image":{"@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/e167594e059fd908b48f144590a46ccd","name":"Silvia Rigotto","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pharmanutra.it\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/74de320c47466acb3ce41afd90e724ba09607692eb64df19e5d1a3518ea9984c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/74de320c47466acb3ce41afd90e724ba09607692eb64df19e5d1a3518ea9984c?s=96&d=mm&r=g","caption":"Silvia Rigotto"},"url":"https:\/\/www.pharmanutra.it\/en\/author\/s-rigotto\/"}]}},"meta_box":[],"_links":{"self":[{"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/posts\/17336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/comments?post=17336"}],"version-history":[{"count":3,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/posts\/17336\/revisions"}],"predecessor-version":[{"id":17373,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/posts\/17336\/revisions\/17373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/media\/17329"}],"wp:attachment":[{"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/media?parent=17336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/categories?post=17336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/tags?post=17336"},{"taxonomy":"anno_documento","embeddable":true,"href":"https:\/\/www.pharmanutra.it\/en\/wp-json\/wp\/v2\/anno_documento?post=17336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}